Home - CF AMR Syndicate

We are working with the community to drive antimicrobial and diagnostic discovery efforts.

About Target Product Profiles, a document by the CF AMR Syndicate

Toolkit

We build enabling tools and resources for antimicrobial and diagnostic development.

Funding

Identifying and supporting promising antimicrobial and diagnostics projects.

Network

Bringing the sector together to accelerate new treatments for CF lung infections.

Scientists working on drug discovery for Cystic Fibrosis AMR, Image by Cambridge Laboratory of Molecular Biology

About

Learn more about the CF AMR Syndicate.

OBN Awards 2024 Winners LinkedIn Banners - Most Impactful Industry Collaboration of the Year - CF-AMR Syndicate

Who we are

In 2019, Medicines Discovery Catapult joined forces with Cystic Fibrosis Trust to form the Cystic Fibrosis Syndicate in Antimicrobial Resistance. The Syndicate expanded, welcoming LifeArc in a tripartite managing partnership.

The CF Syndicate in AMR is a cross-sector initiative that brings together leading experts in CF/AMR from industry, academia, and the clinic with people with Cystic Fibrosis. The collective expertise of the CF AMR Syndicate enables new efforts in the discovery of CF antimicrobials to accelerate translation to the clinic and ultimately bring better treatment options to people affected by CF faster.

Learn more about us

CF AMR Network

Our network facilitates collaboration and knowledge exchange in CF infection research and aims to create a diverse cross-sector collaborative network with the expertise and drive required to drive and accelerate CF antimicrobial development.

Join our network and be part of a collaborative force driving groundbreaking cystic fibrosis antimicrobial research.

Together, we can accelerate the development of new treatments and improve the lives of people with CF.

CF AMR network

Connect with experts

Bringing together a critical mass of individuals and organisations with expertise and capabilities in CF antimicrobial discovery and development.

Join our network

Collaborate effectively

Join our network and be part of a collaborative force driving groundbreaking cystic fibrosis antimicrobial research. Together, we can accelerate the development of new treatments and improve the lives of those affected by this disease.

Join our network

Facilitate discovery

Drive and facilitate introductions across the network to enable collaborative projects, strengthening national and international collaboration in CF antimicrobial research.

Join our network